Send feedback

RAG2 p.Arg464His

c.1391G>A · rs147748696 · VCV432772

Conflicting classifications of pathogenicity Conflicting submitters
Classification
Conflicting classifications of pathogenicity
ClinVar
Review
Conflicting submitters ★☆☆☆
ClinVar · 4 submitters
AlphaMissense
likely benign
0.0751 · ACMG-weighted
gnomAD v4.1
Rare
ultra-rare (popmax 0.0334%, nfe)
Missense predictors
0/3 damaging
AlphaMissense, REVEL, SaProt
Conditions
3
combined immunodeficiency with skin granulomas

Computational evidence

Protein change
AlphaMissense0.0751likely benign
REVEL0.246benign-leaning
SaProtLLR -6.82tolerated
⇒ AlphaMissense, REVEL and SaProt all call this tolerated.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP -1.1GERP -4.7
Regional constrainto/e 0.99unconstrained · MANE · 1,580 bp · p 0.79 · regional, not allelic
Overall
CADD12.39PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.0334% European (non-Finnish) · 394/1,180,014 alleles
Filtering AF 0.0306% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.0295%
Overall 0.0368% 594/1,613,910 alleles · ultra-rare exomes 529/1,461,890 · genomes 65/152,020 · joint denominator
Ancestry group Frequency 1 in
Ashkenazi Jewishnot grpmax-eligible 0.321% 312
Finnishnot grpmax-eligible 0.125% 800
European (non-Finnish)grpmax 0.0334% 2,995
Remaining individualsnot grpmax-eligible 0.0304% 3,289
African / African-American 0.00401% 24,957
Admixed American 0.00333% 29,991
South Asian 0.0011% 91,078

Ashkenazi Jewish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
RAG2
Protein
p.Arg464His
Coding
c.1391G>A
MANE Select
NM_000536
dbSNP
rs147748696
Type
single nucleotide variant
Location
chr11:36592778 (GRCh38)
Gene constraint
LOEUF 0.733 · pLI 0.02 (gnomAD)
Structure
AlphaFold pLDDT 75.98 · 1 PDB
Residue 464
an α-helix
Full RAG2 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/rag2-p-arg464his (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown